Physician profile
Leanne M Molia
NPI 1003908831
$3,378.57
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,896 · 2020: $568 · 2021: $409 · 2022: $196 · 2023: $274 · 2024: $35.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.09 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $1,002.99 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $712.46 | 2019-2021 | |
| Allergan, INC. | $499.32 | 2019-2022 | |
| Alcon Vision LLC | $377.40 | 2022-2024 | Simbrinza, Rocklatan, Rhopressa |
| Novartis Pharmaceuticals Corporation | $282.16 | 2019-2022 | |
| Shire North American Group INC | $186.74 | 2019 | |
| Glaukos Corporation | $136.82 | 2019 | |
| Sun Pharmaceutical Industries INC. | $102.20 | 2020-2021 | |
| Abbvie INC. | $47.17 | 2022 | |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
| Akorn, INC. | $13.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Molia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.